Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 2
2004 6
2005 4
2006 4
2007 3
2008 4
2009 1
2010 1
2011 2
2012 8
2013 4
2014 3
2015 3
2016 1
2017 3
2018 2
2019 7
2020 9
2021 10
2022 3
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

71 results

Results by year

Filters applied: . Clear all
Page 1
Mechanisms of action of duodenal mucosal resurfacing in insulin resistant women with polycystic ovary syndrome.
Kaur V, Dimitriadis GK, Pérez-Pevida B, Bansi DS, Jayasena C, Bate D, Houghton R, Fielding BA, Balfoussia D, Webber L, Miao Y, Mears F, Jackson N, Coppin L, Perez J, Williams M, Johnson B, Umpleby AM, Randeva HS, Miras AD. Kaur V, et al. Metabolism. 2021 Dec;125:154908. doi: 10.1016/j.metabol.2021.154908. Epub 2021 Oct 7. Metabolism. 2021. PMID: 34627875 Clinical Trial.
A randomised, controlled, double blind study to assess mechanistic effects of combination therapy of dapagliflozin with exenatide QW versus dapagliflozin alone in obese patients with type 2 diabetes mellitus (RESILIENT): study protocol.
Brown E, Wilton MM, Sprung VS, Harrold JA, Halford JCG, Stancak A, Burgess M, Howarth E, Umpleby AM, Kemp GJ, Wilding JP, Cuthbertson DJ. Brown E, et al. Among authors: umpleby am. BMJ Open. 2021 Jul 20;11(7):e045663. doi: 10.1136/bmjopen-2020-045663. BMJ Open. 2021. PMID: 34285005 Free PMC article.
Response to Comment on Herring et al. Metabolic Effects of an SGLT2 Inhibitor (Dapagliflozin) During a Period of Acute Insulin Withdrawal and Development of Ketoacidosis in People With Type 1 Diabetes. Diabetes Care 2020;43:2128-2136.
Herring RA, Shojaee-Moradie F, Garesse R, Stevenage M, Jackson N, Fielding BA, Mendis A, Johnsen S, Umpleby AM, Davies M, Russell-Jones DL. Herring RA, et al. Among authors: umpleby am. Diabetes Care. 2021 Mar;44(3):e61. doi: 10.2337/dci20-0072. Diabetes Care. 2021. PMID: 33608329 No abstract available.
71 results